Steffen Lippold

Genentech Inc

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Collaborators (2)

Kamalakar Chatla

Technical Development Scientist

Genentech Inc

UNITED STATES

Jan Terje Andersen

Group leader

University of Oslo

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Steffen Lippold

Research Interests

Make your next move.

Explore related searches

Articles (13)

Collaborators (2)

Kamalakar Chatla

Jan Terje Andersen

Make your next move.

Steffen Lippold

Research Interests

Make your next move.

Explore related searches

Articles (13)

Development of single-chain C1q affinity chromatography–mass spectrometry for the glycoform-resolved characterization of low-affinity immunoglobulin G interactions

Analytical Assessment of sgRNA Impurities and Their Impact on Functional Performance

Assessing mRNA and sgRNA Quality for Cell and Gene Therapy Applications Using Nanopore Direct RNA Sequencing

Charge Detection Mass Spectrometry and a Glu-C/Lys-C Digestion-Based Data-Dependent Approach Suggest Mono-PEGylation of a Heterogenous Therapeutic Protein

Characterization of free light chain impurity in a bispecific antibody

Current Analytical Strategies for mRNA-Based Therapeutics

Benchmarking glycoform-resolved affinity separation – mass spectrometry assays for studying FcγRIIIa binding

Comprehensive Impurity Profiling of mRNA: Evaluating Current Technologies and Advanced Analytical Techniques

Expanding the structural resolution of glycosylation microheterogeneity in therapeutic proteins by salt-free hydrophilic interaction liquid chromatography tandem mass spectrometry

Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses

Function-structure approach reveals novel insights on the interplay of Immunoglobulin G 1 proteoforms and Fc gamma receptor IIa allotypes

CD3 Target Affinity Chromatography Mass Spectrometry as a New Tool for Function-Structure Characterization of T-Cell Engaging Bispecific Antibody Proteoforms and Product-Related Variants

Internal Fragment Ions from Higher Energy Collision Dissociation Enable the Glycoform-Resolved Asn325 Deamidation Assessment of Antibodies by Middle-Down Mass Spectrometry

Collaborators (2)

Kamalakar Chatla

Jan Terje Andersen

Make your next move.